In SSc, sFlt-1, and PlGF have been previously identified as potential biomarkers of pulmonary hypertension (PH) in a prospective cohort study of 300 patients, with higher levels of PlGF and sFlt-1 in patients with PH compared with patients with SSc without PH, respectively.11 Here, PGF is linked to systemic sclerosis.